Cleared Traditional

K201900 - 3D GraftRasp System

K201900 is an FDA 510(k) clearance for 3D GraftRasp System, manufactured by Surgentec. The device is a Class 2 Orthopedic device with product code FMF cleared through the Traditional 510(k) pathway after a 57-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2020
Decision
57d
Days
Class 2
Risk

K201900 is an FDA 510(k) clearance for the 3D GraftRasp System. Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Surgentec (Boca Raton, US). The FDA issued a Cleared decision on September 3, 2020 after a review of 57 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 880.5860 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Surgentec devices

FDA 510(k) Submission Details - K201900

510(k) Number K201900 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 08, 2020
Decision Date September 03, 2020
Days to Decision 57 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
65d faster than avg
Panel avg: 122d · This submission: 57d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 329
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K201900.
S dispensing line
K192770 · Aea Srl · Dec 2020
Sterile Hypodermic Syringe for Single Use, with/without needle, luer/luer-lock, Sterile Insulin Syringe for Single Use, with needle, Sterile Hypodermic needle for Single use
K201284 · Set Medikal Sanayi VE Ticaret Anonim Sirketi · Dec 2020
ARTHROTAP
K201816 · Accuro Technologies, Inc. · Oct 2020
Syringe with safety needle, Safety needle
K193526 · Jiangsu Caina Medical Co.,Ltd · Jul 2020
BD SoloShot Mini Syringe/ BD Auto Disable Syringe
K201234 · Becton, Dickinson and Company · Jul 2020
Orbit Subretinal Delivery System
K200325 · Orbit Biomedical · Jul 2020